FDA Offers Guidance on Development of Antivirals

International Pharmaceutical Regulatory Monitor
KEYWORDS FDA / Guidances
A A

The FDA has published guidelines on nonclinical virology data needed to support a marketing application for antiviral drugs and biological products.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00